- Home
- TPR vs NTRA Comparison
TPR vs NTRA Comparison
Compare TPR & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPR
- NTRA
- Stock Information
- Founded
- TPR 1941
- NTRA 2003
- Country
- TPR United States
- NTRA United States
- Employees
- TPR N/A
- NTRA N/A
- Industry
- TPR Apparel
- NTRA Medical Specialities
- Sector
- TPR Consumer Discretionary
- NTRA Health Care
- Exchange
- TPR Nasdaq
- NTRA Nasdaq
- Market Cap
- TPR 17.5B
- NTRA 18.8B
- IPO Year
- TPR 2000
- NTRA 2015
- Fundamental
- Price
- TPR $106.31
- NTRA $134.58
- Analyst Decision
- TPR Buy
- NTRA Strong Buy
- Analyst Count
- TPR 18
- NTRA 17
- Target Price
- TPR $94.89
- NTRA $184.65
- AVG Volume (30 Days)
- TPR 4.0M
- NTRA 1.3M
- Earning Date
- TPR 08-14-2025
- NTRA 08-07-2025
- Dividend Yield
- TPR 1.32%
- NTRA N/A
- EPS Growth
- TPR 0.55
- NTRA N/A
- EPS
- TPR 3.79
- NTRA N/A
- Revenue
- TPR $6,878,600,000.00
- NTRA $1,831,000,000.00
- Revenue This Year
- TPR $5.47
- NTRA $19.98
- Revenue Next Year
- TPR $2.27
- NTRA $16.16
- P/E Ratio
- TPR $28.05
- NTRA N/A
- Revenue Growth
- TPR 2.67
- NTRA 51.50
- 52 Week Low
- TPR $35.23
- NTRA $92.14
- 52 Week High
- TPR $110.44
- NTRA $183.00
- Technical
- Relative Strength Index (RSI)
- TPR 66.41
- NTRA 33.03
- Support Level
- TPR $105.74
- NTRA $134.81
- Resistance Level
- TPR $109.39
- NTRA $141.00
- Average True Range (ATR)
- TPR 2.49
- NTRA 5.15
- MACD
- TPR -0.41
- NTRA -0.75
- Stochastic Oscillator
- TPR 61.69
- NTRA 10.49
About TPR Tapestry Inc.
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounts for about 80% of its sales and more than 90% of its operating profit. Coach products are sold through 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade, which generated 54% of its sales from handbags in fiscal 2024. Kate Spade is known for its colorful patterns and graphics. Meanwhile, Tapestry's smallest brand, luxury footwear maker Stuart Weitzman, is set to be sold to Caleres in the summer of 2025.
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.